He leads investment strategy at ValueAct Capital, directing concentrated, engagement-oriented activism and growth equity investments across software, healthcare and industrials; Mason G. Morfit brings a track record of negotiating board-level changes, operational improvement plans and multi-year value creation with large institutional capital. Prior roles span senior investment and portfolio management positions in the buy-side, and his investing style blends fundamental research with collaborative governance to unlock enterprise value for long-term shareholders.
He leads investment strategy at ValueAct Capital, directing concentrated, engagement-oriented activism and growth equity investments across software, healthcare and industrials; Mason G. Morfit brings a track record of negotiating board-level changes, operational improvement plans and multi-year value creation with large institutional capital. Prior roles span senior investment and portfolio management positions in the buy-side, and his investing style blends fundamental research with collaborative governance to unlock enterprise value for long-term shareholders.
Deploys concentrated, conviction-driven capital with a multi-year horizon, marrying deep fundamental research and operational due diligence to identify enterprise improvement opportunities in software, healthcare and industrials. Prefers engagement-oriented activism: negotiating board representation, aligning management incentives, and sponsoring turnaround and growth plans to unlock value. Emphasizes rigorous capital-allocation analysis, selective use of leverage, and a clear exit thesis tied to governance milestones. Risk discipline centers on downside protection via structural changes and close portfolio monitoring while seeking asymmetric upside through strategic operational interventions and collaborative stakeholder alignment.
Deploys concentrated, conviction-driven capital with a multi-year horizon, marrying deep fundamental research and operational due diligence to identify enterprise improvement opportunities in software, healthcare and industrials. Prefers engagement-oriented activism: negotiating board representation, aligning management incentives, and sponsoring turnaround and growth plans to unlock value. Emphasizes rigorous capital-allocation analysis, selective use of leverage, and a clear exit thesis tied to governance milestones. Risk discipline centers on downside protection via structural changes and close portfolio monitoring while seeking asymmetric upside through strategic operational interventions and collaborative stakeholder alignment.
| Trades 686 | Longs Won 457/686 66% | Profit Factor 6.22 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $74.14M |
| Average Win $44.68M | Best Trade (Jun 30) $850.97M | Sharpe Ratio -15.65 |
| Average Loss -$14.33M | Worst Trade (Sep 29) -$248.07M | Z-Score -10.36 (100%) |
| Commissions $0 | Avg. Trade Length 1y 10m 4w | Expectancy $24.98M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.23% |
| Consecutive Losing Trades | 444 | 399 | 355 | 311 | 266 | 222 | 178 | 133 | 89 | 44 |